The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units

References

• KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.
   PubMed Web of Science ®Google Scholar
• Brown JR, Rezaee ME, Hisey WM, et al. Reduced mortality associated with acute kidney injury requiring dialysis in the United States. Am J Nephrol. 2016;43(4):261–270.
   PubMed Web of Science ®Google Scholar
• Hussain S, Piering W, Mohyuddin T, et al. Outcome among patients with acute renal failure needing continuous renal replacement therapy: a single center study. Hemodial Int. 2009;13(2):205–214.
   PubMed Web of Science ®Google Scholar
• Stads S, Fortrie G, van Bommel J, et al. Impaired kidney function at hospital discharge and long-term renal and overall survival in patients who received CRRT. CJASN. 2013;8(8):1284–1291.
   PubMed Web of Science ®Google Scholar
• Prasad B, Urbanski M, Ferguson TW, et al. Early mortality on continuous renal replacement therapy (CRRT): the prairie CRRT study. Can J Kidney Health Dis. 2016;3:36.
   PubMedGoogle Scholar
• Kao CC, Yang JY, Chen L, et al. Factors associated with poor outcomes of continuous renal replacement therapy. PLOS One. 2017;12(5):e0177759.
   PubMed Web of Science ®Google Scholar
• Bleeding episodes during dialysis. Safety VNCfP: VA Central Office; 2008.
   Google Scholar
• VHA handbook 1042.01 criteria and standards for dialysis in VA. Department of Veterans Affairs Veterans Health Administration; 2016.
   Google Scholar
• Nash DM, Przech S, Wald R, et al. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017;41:138–144.
   PubMed Web of Science ®Google Scholar
• Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20.
   PubMed Web of Science ®Google Scholar
• Graham P, Lischer E. Nursing issues in renal replacement therapy: organization, manpower assessment, competency evaluation and quality improvement processes. Semin Dial. 2011;24(2):183–187.
   PubMed Web of Science ®Google Scholar
• Redsense dialysis alarm for patients undergoing needle access procedures. Safety VNCfP: VA Central Office; 2010.
   Google Scholar
• Baldwin I. Is there a need for a nurse emergency team for continuous renal replacement therapy? Contrib Nephrol. 2007;156:191–196.
   PubMed Web of Science ®Google Scholar
• Honore PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif. 2013;35(4):279–284.
   PubMed Web of Science ®Google Scholar
• Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract. 2005;20(2):176–191.
   PubMedGoogle Scholar
• Bellomo R, Tan HK, Bhonagiri S, et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs. 2002;25(4):261–268.
   PubMed Web of Science ®Google Scholar
• Scheinkestel CD, Adams F, Mahony L, et al. Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition. 2003;19(9):733–740.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ivany JN, Perkovic V, et al. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease. Cochrane Database Syst Rev. 2016;4:CD009631.
   PubMedGoogle Scholar
• Quenot JP, Helms J, Bourredjem A, et al. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial. Ann Intensive Care. 2019;9(1):75.
   PubMedGoogle Scholar
• Czepizak CA, O'Callaghan JM, Venus B. Evaluation of formulas for optimal positioning of central venous catheters. Chest. 1995;107(6):1662–1664.
   PubMed Web of Science ®Google Scholar
• Fryar CD, Gu Q, Ogden CL. Anthropometric reference data for children and adults: United States. Vital Health Stat Series. 2007;252(2010):1–48.
   Google Scholar
• Zarbock A, Küllmar M, Kindgen-Milles D, RICH Investigators and the Sepnet Trial Group, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629–1639.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38(1):20–28.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang F, Wang Y, et al. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding. Sci Rep. 2019;9(1):6607.
   PubMedGoogle Scholar
• Ricci D, Panicali L, Facchini MG, et al. Citrate anticoagulation during continuous renal replacement therapy. Contrib Nephrol. 2017; 190:19–30.
   PubMed Web of Science ®Google Scholar
• Wu MY, Hsu YH, Bai CH, Lin YF, et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012; 59(6):810–818.
   PubMed Web of Science ®Google Scholar
• Group K. KDIGO clinical practical guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
   Web of Science ®Google Scholar
• Trotman RL, Williamson JC, Shoemaker DM, et al. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin Infect Dis. 2005;41(8):1159–1166.
   PubMed Web of Science ®Google Scholar
• Wilson FP, Berns JS. Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD). Clin Nephrol. 2012;77(4):329–331.
   PubMed Web of Science ®Google Scholar
• Seyler L, Cotton F, Taccone FS, et al. Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care. 2011;15(3):R137.
   PubMed Web of Science ®Google Scholar
• Shaw AR, Chaijamorn W, Mueller BA. We underdose antibiotics in patients on CRRT. Semin Dial. 2016;29(4):278–280.
   PubMed Web of Science ®Google Scholar
• Keough LA, Krauss A, Hudson JQ. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis. Int J Clin Pharm. 2018;40(5):1250–1256.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Kays MB, Mueller BA. Use of Monte Carlo simulations to determine optimal carbapenem dosing in critically ill patients receiving prolonged intermittent renal replacement therapy. J Clin Pharmacol. 2016;56(10):1277–1287.
   PubMed Web of Science ®Google Scholar
• Jang SM, Gharibian KN, Lewis SJ, et al. A Monte Carlo simulation approach for beta-lactam dosing in critically ill patients receiving prolonged intermittent renal replacement therapy. J Clin Pharmacol. 2018;58(10):1254–1265.
   PubMed Web of Science ®Google Scholar
• Gharibian KN, Mueller BA. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach. Clin Nephrol. 2016;86(7):43–50.
   PubMedGoogle Scholar
• Mei JP, Ali-Moghaddam A, Mueller BA. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis. Int J Clin Pharm. 2016;38(1):127–134.
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Chakravarthi MR, Ricci Z, ADQI Consensus Group, et al. Precision continuous renal replacement therapy and solute control. Blood Purif. 2016;42(3):238–247.
   PubMed Web of Science ®Google Scholar